| Database ID | Agent | Target | Cancer Type | Detail |
| DB00226 | custirsen | Clusterin (CLU) | prostate cancer | view |
| DB00227 | custirsen | Clusterin (CLU) | prostate cancer | view |
| DB00228 | oblimersen sodium | Apoptosis regulator Bcl2 | prostate cancer | view |
| DB00229 | AT101 | Bcl2, BclxL, Mcl1, and Bclw | prostate cancer | view |
| DB00230 | sirolimus/rapamycin | Serine/threonineprotein kinase mTOR | prostate cancer | view |
| DB00231 | BGT226 | PI3K gamma
Serine/threonineprotein kinase mTOR | advanced solid tumors | view |
| DB00232 | ridaforolimus | Serine/threonineprotein kinase mTOR | prostate cancer | view |
| DB00233 | everolimus | mammalian target of rapamycin (mTOR) | prostate cancer | view |
| DB00234 | everolimus | mammalian target of rapamycin (mTOR) | prostate cancer | view |
| DB00235 | ridaforolimus | Serine/threonineprotein kinase mTOR | prostate cancer | view |
| DB00236 | temsirolimus | Serine/threonineprotein kinase mTOR | prostate cancer | view |
| DB00237 | everolimus | Serine/threonineprotein kinase mTOR | prostate cancer | view |
| DB00238 | enzalutamide (formerly called MDV3100) | androgenreceptor | prostate cancer | view |
| DB00239 | veliparib | Poly [ADPribose] polymerase1 | prostate cancer | view |
| DB00240 | olaparib | Poly [ADPribose] polymerase1 | advanced solid tumors | view |